In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

8th CAR-TCR Summit

Aug 29, 2023 - 09:00 AM - Sep 01, 06:00 PM
Hanson Wade
Hynes Convention Center
900, Boylston St

ZIP: 02115
Phone: +442031418700

Ticket Price: USD 1049.00 - USD 8499.00

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.

This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.  

The 8th CAR-TCR Summit is returning to Boston as the industry's trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.  

Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.  

Tickets: https://go.evvnt.com/1657045-2?pid=1052
Brochure: https://go.evvnt.com/1657045-3?pid=1052
YouTube: https://go.evvnt.com/1657045-4?pid=1052

Drug Developer Pricing - 3 Day Conference Only: USD 4649.00,
Start Up Pricing - 3 Day Conference Only: USD 3549.00,
Standard Pricing - 3 Day Conference Only: USD 6649.00,
Drug Developer Pricing - 3-Day Conference + (Workshop Day OR Focus Day OR Bootcamp Day): USD 5999.00,
Start Up Pricing - 3-Day Conference + (Workshop Day OR Focus Day OR Bootcamp Day): USD 4449.00,
Standard Pricing - 3-Day Conference + (Workshop Day OR Focus Day OR Bootcamp Day): USD 8499.00,
Drug Developer Pricing - Bootcamp Day Only: USD 1499.00,
Start Up Pricing - Bootcamp Day Only: USD 1049.00,
Standard Pricing - Bootcamp Day Only: USD 1999.00

Speakers: Nelly Viseux, Senior Vice President, Process and Analytical Development and Clinical Manufacturing, 2seventy bio , Chris Bartiromo, Executive Director, Worldwide Value and Access Strategy, Cell Therapy, Lymphoma and Myeloma, Bristol Myers Squibb, John Rossi, Vice President, Head of Translational Medicine, CARGO Therapeutics, Laura McWright, Deputy Director, Seamless Care Models Group, Centers for Medicare and Medicaid Services, Stephan Grupp, Director, Cancer Immunotherapy and Cell Therapy, Children's Hospital of Philadelphia, Peter Marks, Director, Center for Biologics Evaluation and Research, FDA, Frank Neumann, Senior Vice President and Global Head of Clinical Developmentc, Kite, A Gilead Company, Jennifer Brogdon, Head of Cell and Gene Therapies, Immuno-Oncology and Hematology, Novartis Institutes of BioMedical Research , Gang Zeng, President and Chief Executive Officer, T-Cure Biosciences

Event Categories
Keywords: conference , pharmaceutical


Events Calendar

30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2

Event Location


VIP Life Time Subscription to our Newsletters!